Vaccine shows promise in generating immune response to KRAS mutations in pancreatic cancer study.
Five U.S. hospitals rank among the world’s top oncology centers in 2027, showcasing one of...
The FDA approves ropeginterferon alfa-2b-njft for essential thrombocythemia, the first new treatment for the rare...
Breast cancer diagnosis taught Dr. Molly Greenwade, an oncologist, lessons on early detection while juggling...
A study in Nature overturns the assumption that longer sleep is universally better for aging....
Hypertension cases in England reveal 37.2% prevalence, with 58.8% undetected per 1.4 million adult study,...
Support brain health naturally with new habits like crocheting and exercise, one of the best...
Kohler Wisconsin redefines wellness retreats with integrated design, blending movement, recovery, and architecture into a...
FDA reviews two novel ADHD drug candidates in late-stage development, offering new approaches to treatment.
Zorevunersen dravet patients showed adaptive gains over two years, surpassing standard antiseizure therapy in a...